Alpha-synuclein stimulation of astrocytes: Potential role for neuroinflammation and neuroprotection

Oxidative Medicine and Cellular Longevity

Volumn 3, Issue 4, 2010, Pages 283-287

  Lee, He Jin ^a,b   Kim, Changyoun ^b   Lee, Seung Jae ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Alpha synuclein; Amyloid; Neurodegeneration; Neuroinflammation; Parkinson's disease

Indexed keywords

AMYLOID; NEURODEGENERATION; NEUROINFLAMMATION; PARKINSON'S DISEASE; SYNUCLEIN;

DISEASES; GLYCOPROTEINS; MOLECULAR BIOLOGY;

PROTEINS;

ALPHA SYNUCLEIN; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 1; CXCL11 CHEMOKINE; CXCL16 CHEMOKINE; CXCL2 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 5; RANTES; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA;

ASTROCYTE; BRADYKINESIA; CELL MIGRATION; CYTOKINE PRODUCTION; EXOCYTOSIS; GENE EXPRESSION PROFILING; HUMAN; IMMUNE RESPONSE; IMMUNITY; LEWY BODY; MACROPHAGE; MICROGLIA; MONOCYTE; MUSCLE RIGIDITY; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; REVIEW; SYNAPTIC TRANSMISSION; TREMOR; DEGENERATIVE DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ALPHA-SYNUCLEIN; ASTROCYTES; HUMANS; NEURODEGENERATIVE DISEASES; NEUROPROTECTION; PARKINSON DISEASE;

EID: 77957371012     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.3.4.12809     Document Type: Review

References (24)

1. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol 119:7-35.
2. Yanagida T, Tsushima J, Kitamura Y, Yanagisawa D, Takata K, Shibaike T, et al. Oxidative stress induction of DJ-1 protein in reactive astrocytes scavenges free radicals and reduces cell injury. Oxid Med Cell Longev 2009; 2:36-42.
3. Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol 2007; 28:138-45.
4. Hirsch EC, Hunot S, Hartmann A. Neuroinflammatory processes in Parkinson's disease. Parkinsonism Relat Disord 2005; 11:9-15.
5. Fahn S, Sulzer D. Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx 2004; 1:139-54.
6. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24:197-211.
7. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci USA 1998; 95:6469-73. (Pubitemid 28249037)
8. Farrer MJ. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 2006; 7:306-18.
9. Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009; 41:1303-7.
10. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009; 41:1308-12.
11. Jang A, Lee HJ, Suk JE, Jung JW, Kim KP, Lee SJ. Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions. J Neurochem 2010; 113:1263-74.
12. Lee HJ, Patel S, Lee SJ. Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 2005; 25:6016-24.
13. Lee HJ, Suk JE, Bae EJ, Lee JH, Paik SR, Lee SJ. Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int J Biochem Cell Biol 2008; 40:1835-49.
14. Lee HJ, Suk JE, Bae EJ, Lee SJ. Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. Biochem Biophys Res Commun 2008; 372:423-8.
15. Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 2009; 106:13010-5.
16. Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S, et al. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 2010; 285:9262-72.
17. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000; 117:1162-72.
18. Mogi M, Harada M, Narabayashi H, Inagaki H, Minami M, Nagatsu T. Interleukin (IL)-1beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci Lett 1996; 211:13-6.
19. Reale M, Greig NH, Kamal MA. Peripheral chemocytokine profiles in Alzheimer's and Parkinson's diseases. Mini Rev Med Chem 2009; 9:1229-41.
20. Savarin-Vuaillat C, Ransohoff RM. Chemokines and chemokine receptors in neurological disease: raise, retain or reduce? Neurotherapeutics 2007; 4:590-601.
21. Song JH, Bellail A, Tse MC, Yong VW, Hao C. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. J Neurosci 2006; 26:3299-308.
22. Kim HC, Bing G, Kim SJ, Jhoo WK, Shin EJ, Bok Wie M, et al. Kainate treatment alters TGF-beta3 gene expression in the rat hippocampus. Brain Res Mol Brain Res 2002; 108:60-70.
23. Li K, Xue B, Wang Y, Wang X, Wang H. Ventral mesencephalon astrocytes are more efficient than those of other regions in inducing dopaminergic neurons through higher expression level of TGF-beta3. J Mol Neurosci 2009; 37:288-300.
24. Bertollini C, Ragozzino D, Gross C, Limatola C, Eusebi F. Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices. Neuropharmacology 2006; 51:816-21. (Pubitemid 44286937)